Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibraheem H Motabi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Blood Reviews|October 17, 2012
Advances in stem cell mobilizationIbraheem H Motabi, John F DiPersio
Hematology/Oncology and Stem Cell Therapy|December 27, 2015
CD56 and RUNX1 isoforms in AML prognosis and their therapeutic potentialSyed Z A Zaidi, Ibraheem H Motabi, Ali Al-Shanqeeti
Hematology/Oncology and Stem Cell Therapy|October 7, 2018
Durable remission of a patient with primary cutaneous CD8<sup>+</sup> aggressive epidermotropic cytotoxic T-cell lymphomaShaima M Al Aoun, Shahid Iqbal, Tahani M AlHalouli, et al.
Cureus|August 2, 2019
Systemic Lupus Erythematosus Presenting as Hematoma of the Hand Due to Acquired Inhibitors to Factor VIII: Early and Prolonged Remission Achieved with Upfront RituximabAbdul Rehman Z Zaidi, Mohammed AlSheef, Ibraheem H Motabi, et al.
Clinical Case Reports|July 10, 2023
Favorable outcome of <i>PML-RARα</i> short isoform and <i>FLT3-ITD</i> mutation in a patient with several adverse prognostic markers: A case reportMohammed A Bafail, Rahaf AlTahan, Manar A Samman, et al.
Pakistan Journal of Medical Sciences|January 14, 2017
Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi ArabiaShahid Iqbal, Syed Z A Zaidi, Ibraheem H Motabi, et al.
Hematology/Oncology and Stem Cell Therapy|January 12, 2023
Outcome of Myeloma Patients with COVID-19 on Active Lenalidomide-Based Therapy: Does Lenalidomide Protect From Severe COVID-19?Imran K Tailor, Nawal F Alshehry, Syed Z Zaidi, et al.
Cureus|January 19, 2023
The Successful Implementation of a Modified Pediatric Acute Lymphoblastic Leukemia Protocol to Treat an Elderly Patient With T-cell Lymphoblastic Leukemia: A Case ReportIbraheem H Motabi, Yara A Alsaif, Mohammed K Bin Shuayl, et al.
The American Journal of Case Reports|September 13, 2020
Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast CrisisAhmed A Bin Salman, Abdul Rehman Zia Zaidi, Syed Yasir Altaf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 31, 2016
Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell TransplantIbraheem H Motabi, Armin Ghobadi, Jingxia Liu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Blood Reviews|October 17, 2012
Advances in stem cell mobilizationIbraheem H Motabi, John F DiPersio
Hematology/Oncology and Stem Cell Therapy|December 27, 2015
CD56 and RUNX1 isoforms in AML prognosis and their therapeutic potentialSyed Z A Zaidi, Ibraheem H Motabi, Ali Al-Shanqeeti
Hematology/Oncology and Stem Cell Therapy|October 7, 2018
Durable remission of a patient with primary cutaneous CD8<sup>+</sup> aggressive epidermotropic cytotoxic T-cell lymphomaShaima M Al Aoun, Shahid Iqbal, Tahani M AlHalouli, et al.
Cureus|August 2, 2019
Systemic Lupus Erythematosus Presenting as Hematoma of the Hand Due to Acquired Inhibitors to Factor VIII: Early and Prolonged Remission Achieved with Upfront RituximabAbdul Rehman Z Zaidi, Mohammed AlSheef, Ibraheem H Motabi, et al.
Clinical Case Reports|July 10, 2023
Favorable outcome of <i>PML-RARα</i> short isoform and <i>FLT3-ITD</i> mutation in a patient with several adverse prognostic markers: A case reportMohammed A Bafail, Rahaf AlTahan, Manar A Samman, et al.
Pakistan Journal of Medical Sciences|January 14, 2017
Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi ArabiaShahid Iqbal, Syed Z A Zaidi, Ibraheem H Motabi, et al.
Hematology/Oncology and Stem Cell Therapy|January 12, 2023
Outcome of Myeloma Patients with COVID-19 on Active Lenalidomide-Based Therapy: Does Lenalidomide Protect From Severe COVID-19?Imran K Tailor, Nawal F Alshehry, Syed Z Zaidi, et al.
Cureus|January 19, 2023
The Successful Implementation of a Modified Pediatric Acute Lymphoblastic Leukemia Protocol to Treat an Elderly Patient With T-cell Lymphoblastic Leukemia: A Case ReportIbraheem H Motabi, Yara A Alsaif, Mohammed K Bin Shuayl, et al.
The American Journal of Case Reports|September 13, 2020
Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast CrisisAhmed A Bin Salman, Abdul Rehman Zia Zaidi, Syed Yasir Altaf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 31, 2016
Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell TransplantIbraheem H Motabi, Armin Ghobadi, Jingxia Liu, et al.
Pageof 2